0659 GMT - Hygeia Healthcare's share buyback program of at least 300 million yuan reflects management's view that the stock is undervalued, which could improve investor sentiment, Citi Research analysts say in a note. Hygeia is funding the buyback with internal cash flow, reinforcing its shift to a more cash-generative business model without straining its improving financial position, Citi says. The buyback could provide technical support and a visible demand floor for the shares in the open market over the near term, Citi adds. The combination of direct buying and improved market perception could drive the stock higher over the next 90 days. Shares last traded at HK$12.11. (jason.chau@wsj.com)

(END) Dow Jones Newswires

December 16, 2025 01:59 ET (06:59 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.